ASPRUZYO SPRINKLE
Ranolazine
- Strength
- 1000 mg/1
- Form
- Granule
- Class
- Anti-anginal
SUN PHARMACEUTICAL INDUSTRIES, INC.
Not stocked by us — reference only
Listed by AvPAK
| Dosage form | Tablet, Film Coated, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Anti-anginal |
| Approval route | ANDA — approved generic |
| NDC code | 50268-723 |
| FDA application | ANDA209953 |
| RxNorm concept | 616749 |
| Package sizes listed | 1 |
| Marketed since | September 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Ranolazine
SUN PHARMACEUTICAL INDUSTRIES, INC.
Not stocked by us — reference only
A2A Integrated Pharmaceuticals
Not stocked by us — reference only
Zameer Pharmaceuticals LLC
Not stocked by us — reference only
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
Lupin Pharmaceuticals, Inc.
Not stocked by us — reference only
Zydus Lifesciences Limited
Not stocked by us — reference only
Proficient Rx LP
Not stocked by us — reference only
Viona Pharmaceuticals Inc
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.